UPDATE : Monday, June 17, 2019
상단여백
[ASCO 2019] ‘POLO study opens a new era for treating pancreatic cancer patients’
CHICAGO, Ill. -- AstraZeneca and MSD, also known as Merck & Co. inside the ...
by Lee Han-soo, KBR corresponden  |  2019-06-03 16:18
라인
[ASCO 2019]Novartis’ Kisqali aims to make comeback with new trial results
CHICAGO, Ill. -- Novartis Kisqali, a cyclin-dependent kinase (CDK) 4/6 inhi...
by Lee Han-soo, KBR correspondent  |  2019-06-03 13:41
라인
[ASCO 2019]Korea expanding presence in global oncology field
CHICAGO, Ill. -- American Society of Clinical Oncology (ASCO) 2019 kicked o...
by Lee Han-soo, KBR correspondent  |  2019-06-03 11:17
라인
[ASCO 2019]Roche CEO unveils his company’s future direction at ASCO 2019
CHICAGO, Ill. -- Roche Pharmaceuticals is one of is the largest healthcare ...
by Lee Han-soo, KBR correspondent  |  2019-06-03 11:09
라인
[ASCO 2019]'Asia vital region for Roche’
CHICAGO, Ill. -- The American Society of Clinical Oncology (ASCO) is one of...
by Lee Han-soo, KBR correspondent  |  2019-06-03 11:01
라인
Hanmi’s hypertension drug was effective in phase-4 study 
Hanmi Pharmaceutical’s new combination drug Amosartan (losartan/amlodipine)...
by Jeong Sae-im  |  2019-05-31 16:05
라인
AbbVie’s chronic lymphocytic leukemia drug wins Korean license
AbbVie Korea said it obtained the Ministry of Food and Drug Safety’s approv...
by Park Gi-taek  |  2019-05-30 15:14
라인
HIV prevention pill to get insurance benefit in Korea
The local medical community is likely to use a drug to prevent HIV infectio...
by Kim Yun-mi  |  2019-05-30 13:25
라인
Daiichi Sankyo to co-promote Daewoong's hypertension treatment
Daiichi Sankyo Korea has signed an agreement with Daewoong to co-promote Ol...
by Lee Han-soo  |  2019-05-29 14:50
라인
‘Enstilum treats all psoriasis from mild to severe ones’
Enstilum Foam (betamethasone dipropionate/calcipotriol), a foam-type treatm...
by Kim Yun-mi  |  2019-05-28 14:44
라인
Indonesia gave nods to Medytox's hyaluronic acid filler
Medytox said Tuesday that it has received sales approval for its Neuramis l...
by Lee Han-soo  |  2019-05-28 14:42
라인
Seoul revokes sales license of Invossa-K, prosecutes Kolon Life Science
The Ministry of Food and Drug Safety has revoked the sales approval for Kol...
by Lee Han-soo  |  2019-05-28 11:31
라인
Corestem applies for FDA meet on Lou Gehrig's drug
Corestem said Monday that it has applied for a pre-investigational new drug...
by Lee Han-soo  |  2019-05-27 17:51
라인
Medytox suspected of GMP violation filed at anti-corruption commission
Medytox, the Korean botulinum toxin maker, is suspected of breaching Good M...
by Jeong Sae-im  |  2019-05-27 15:52
라인
HanAll's global partner starts P2 trial of Graves' ophthalmopathy treatment
Immunovant, HanAll Biopharma's global partner, has begun administering ...
by Lee Han-soo  |  2019-05-24 14:44
라인
OliX confident of its age-related macular degeneration treatment’s efficacy
OliX Pharmaceutical said it plans to submit an investigational new drug app...
by Lee Han-soo  |  2019-05-23 13:48
라인
Sillajen, CHA Hospital to co-develop immunotherapy
Sillajen said Wednesday it has entered an agreement with CHA Bundang Hospit...
by Lee Han-soo  |  2019-05-22 18:26
라인
SK Bioscience's shingles vaccine increases market share
Skyzoster, the first shingles vaccine domestically developed by SK Bioscien...
by Lee Han-soo  |  2019-05-22 17:04
라인
Handok, Sanofi to promote vaccines jointly
Handok said Wednesday that it has agreed with Sanofi Pasteur to co-promote ...
by Lee Han-soo  |  2019-05-22 15:48
라인
‘Dupixent is sole systemic, long-term treatment for atopic dermatitis’
Sanofi Genzyme is strengthening its position in the local atopic dermatitis...
by Lee Han-soo  |  2019-05-22 14:44
여백
여백
여백
Back to Top